Entourage Health Corp.
ETRGF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.00 | -0.00 |
| FCF Yield | 28.28% | -198.71% | -52.37% | 39.61% |
| EV / EBITDA | -162.02 | -51.49 | 304.20 | -14.71 |
| Quality | ||||
| ROIC | -12.17% | -32.29% | 2.63% | -61.47% |
| Gross Margin | 30.08% | 12.88% | 46.85% | -43.99% |
| Cash Conversion Ratio | -0.12 | 0.63 | 0.29 | -0.10 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.04% | -2.22% | -2.18% | -1.24% |
| Free Cash Flow Growth | 114.77% | -268.20% | -219.99% | 2,502.07% |
| Safety | ||||
| Net Debt / EBITDA | -158.86 | -50.49 | 297.60 | -14.34 |
| Interest Coverage | -0.16 | -0.52 | 0.06 | -1.36 |
| Efficiency | ||||
| Inventory Turnover | 0.61 | 0.72 | 0.62 | 1.43 |
| Cash Conversion Cycle | 130.62 | 121.60 | 127.43 | 84.02 |